Table X.

Nondisplaceable binding potentials (BP_NDs) in volumes of interest (VOIs) of participants who underwent positron emission tomography (PET) of the brain following the intravenous administration of 444 MBq (12 mCi) 2-[¹⁸F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[¹⁸F]FA)

Age in years	Male sexa	2-[18F]FA	Th	F	T	P	O	C	Fu
22	1	413.29 (11.17)	1.57	0.05	0.00	0.00	0.07	0.12	0.00
23	1	679.32 (18.36)	1.24	0.08	−0.16	−0.10	−0.17	−0.09	−0.14
23	0	415.51 (11.23)	1.12	0.08	−0.16	−0.14	−0.23	−0.07	−0.15
31	0	697.08 (18.84)	1.36	0.04	−0.09	−0.04	−0.08	−0.02	−0.10
45	1	421.80 (11.40)	0.51	0.10	0.02	0.14	0.038	0.11	0.03
47	1	444.00 (12.00)	0.28	0.22	0.05	0.22	0.053	0.14	0.048
49	1	425.13 (11.49)	0.37	0.19	0.15	0.23	0.17	0.29	0.13
51	1	433.27 (11.71)	0.69	−0.15	−0.19	−0.13	−0.13	−0.17	−0.15
53	1	448.44 (12.12)	0.70	0.20	0.08	0.24	0.10	0.15	0.06
56	0	435.12 (11.76)	0.48	0.07	−0.04	0.08	−0.05	0.04	−0.01

2-[¹⁸F]FA = Dose of 2-[¹⁸F]FA in MBq (mCi); Th = Thalamus; F = Frontal cortex; T = Temporal cortex; P = Parietal cortex; O = Occipital cortex; C = Cingulate cortex; Fu = Fusiform gyrus.

^a0 = absent, 1 = present.